Reproduction   citetrack
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  

Reproduction (2005) 129 747-755
DOI: 10.1530/rep.1.00691
Copyright © 2005 Society for Reproduction and Fertility
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coy, P.
Right arrow Articles by Matás, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coy, P.
Right arrow Articles by Matás, C.

RESEARCH

Birth of piglets after transferring of in vitro-produced embryos pre-matured with R-roscovitine

Pilar Coy, Raquel Romar, Salvador Ruiz, Sebastián Cánovas, Joaquín Gadea, Francisco García Vázquez and Carmen Matás

Departamento de Fisiología, Facultad de Veterinaria, Universidad de Murcia, Murcia 30071, Spain

Correspondence should be addressed to P Coy; Email: pcoy{at}um.es

The objectives of this study were to evaluate: (1) the nuclear maturation, (2) the intracellular glutathione (GSH) content, (3) the normality of fertilization and (4) full development after transplantation of embryos derived from porcine oocytes pre-cultured with 50 µmol/l roscovitine (an inhibitor of p34cdc2/cyclin B kinase) for 22 h. After treatment with roscovitine, the nuclear configuration of oocytes (Hoechst staining) was comparable with those examined just after collection: the majority of oocytes were arrested at the germinal vesicle (GV) 1 stage (63.2%). Roscovitine-treated oocytes progressed through meiosis to the metaphase II stage in a conventional step-wise in vitro maturation (IVM) program for 44 h in a proportion similar to control ones (>85.0%). When roscovitine-treated oocytes and non-treated oocytes were matured for 44 h and then co-cultured with fresh spermatozoa for 18 h, no differences were observed in oocyte penetrability, proportion of monospermic penetration and male pronuclear formation (>87%). Roscovitine increased the GSH synthesis in oocytes at 22 h, whereas, after 44 h, roscovitine-treated oocytes had similar amounts of GSH to non-treated oocytes. Finally, surgical transfer of zygotes at 22–24 h post-insemination, derived from roscovitine-treated oocytes, resulted in one pregnancy with 12 piglets born; control non-treated zygotes resulted in one pregnancy and 10 piglets born. The full-term developmental ability of mammalian oocytes pre-cultured with roscovitine prior to IVM is thereby demonstrated. This validation is important before the introduction of roscovitine into routine procedures.




This article has been cited by other articles:


Home page
Hum ReprodHome page
Y.-m. Shu, H.-t. Zeng, Z. Ren, G.-l. Zhuang, X.-y. Liang, H.-w. Shen, S.-z. Yao, P.-q. Ke, and N.-n. Wang
Effects of cilostamide and forskolin on the meiotic resumption and embryonic development of immature human oocytes
Hum. Reprod., March 1, 2008; 23(3): 504 - 513.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
S. Canovas, P. Coy, and E. Gomez
First Steps in the Development of a Functional Assay for Human Sperm Using Pig Oocytes
J Androl, March 1, 2007; 28(2): 273 - 281.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Copyright © 2005 by the Society for Reproduction and Fertility.